project id: TCGA-BRCA; case submitter id: TCGA-AC-A7VC; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.62; rna integrity number: 7.6; age at index: 56; days to birth: -20479; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 20479; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8575/3; primary diagnosis: Metaplastic carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 63; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-AC-A7VC-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 2.0; percent necrosis: 10.0; percent neutrophil infiltration: 2.0; percent normal cells: 20.0; percent stromal cells: 10.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;